Fisons Intal Inhaler
Executive Summary
Patent office denied firm's request for patent extension of the cromolyn sodium inhaler because approval of the product in December did not represent the first permitted commercial marketing of the active ingredient. The ingredient was first approved in 1973 as Intal in capsule form.